Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood.
The iconic red-capped, white-dotted toadstool represents the archetypal idea of a mushroom in most people’s minds, yet few are aware of its therapeutic potential as a psychoactive fungus.
“We know it s often associated with stress reduction, with pain reduction, with longevity. There s lots of anecdotal evidence of its value in particularly the native peoples living in the northern parts of Asia,” says Professor David Nutt, a world-leading neuropsychopharmacologist with extensive experience researching psychoactive substances.
As public, scientific and financial interest in psychoactive mushrooms gains momentum, Amanita Muscaria is catching the eye of investors in the psychedelics sector.
LSD and the bike ride that changed the world Known as Bicycle Day, on April 19 a young Albert Hofmann took a trip that revolutionized the face of psychedelics.
Author of the article: Sam Riches
Publishing date: Apr 19, 2021 • 3 hours ago • 8 minute read On April 19, 1943, Swiss chemist Albert Hofmann intentionally dosed himself with LSD. Photo by AFP/Getty Images, Sam Riches, illustration by Sam Riches
Article content
This story first appeared in Weekend Dispensary, a weekly newsletter from The GrowthOp. Signup now to get a story delivered to your inbox every Saturday.
In the spring of 1943, Swiss chemist Albert Hofmann took a bicycle trip like no other.
Aikido Pharma Inc. (NASDAQ: AIKI)Penny Stocks To Watch #1: Havn Life Sciences (OTC: HAVLF) (CSE: HAVN)
Many of these psychedelic-focused companies are working on R&D., But few of them have notable names that helped carve out prior âfringe industriesâ like cannabis. In Havnâs case, the former CEO of Aphria (NASDAQ: APHA), Vic Neufeld, sits as the Executive Chairman. Other Aphria alumni like Gary Long, its Chief Scientific Officer, was Aphriaâs former CSO. Other C-level members like Tim Moore and Eli Dusenbury were also part of the early cannabis boom related to public markets. Now, theyâve all taken positions at Havn.
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.